Cube Dx
Cube Dx was founded in 2015 and is located in St. Valentin (Austria). The company focuses on the development, production and distribution of multiplex tests for in-vitro diagnostics in clinical routine. Multiplex diagnostics allow for the identification in parallel of a variety of significant parameters (bacteria, fungi, resistance markers, etc.) in a single test, requiring only a minimal amount of sample material. Cube Dx entirely new multiplex technology - the hybcell – is the world's first cylindrical microarray – delivers speedy and reliable results with minimal effort. The hyborg – a completely automated device – processes the samples fully independently and without any intervention by the user. The Cube Dx assay is based on compact sequencing and is designed to address especially those complex diagnostic challenges where fast answers are essential.
Cube Dx was founded in 2015 and is located in St. Valentin (Austria). The company focuses on the development, production and distribution of multiplex tests for in-vitro diagnostics in clinical routine. Multiplex diagnostics allow for the identification in parallel of a variety of significant parameters (bacteria, fungi, resistance markers, etc.) in a single test, requiring only a minimal amount of sample material. Cube Dx entirely new multiplex technology - the hybcell – is the world's first cylindrical microarray – delivers speedy and reliable results with minimal effort. The hyborg – a completely automated device – processes the samples fully independently and without any intervention by the user. The Cube Dx assay is based on compact sequencing and is designed to address especially those complex diagnostic challenges where fast answers are essential.